Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial
Year: 2019
Type: article
Source: European Journal of Cancer
Authors: Keisuke Kosumi, Tsuyoshi Hamada, Sui Zhang, Li Liu, Annacarolina da Silva, Hideo Koh, Tyler S. Twombly, Kosuke Mima, Teppei Morikawa, Mingyang Song, Jonathan A. Nowak, Reiko Nishihara, Leonard B. Saltz, Donna Niedzwiecki, Fang-Shu Ou, Tyler Zemla, Robert J. Mayer, Hideo Baba, Kimmie Ng, Marios Giannakis, Xuehong Zhang, Kana Wu, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Jeffrey A. Meyerhardt, Shuji Ogino
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Kumamoto University, Huazhong University of Science and Technology, Osaka City University, The University of Tokyo, Massachusetts General Hospital, Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, Duke University, Mayo Clinic, Broad Institute, Dana-Farber Brigham Cancer Center, Massachusetts Institute of Technology, Yale Cancer Center, Yale University, Smilow Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: American Association for Cancer Research, Pfizer, Entertainment Industry Foundation, Ohio State University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Mitsukoshi Health and Welfare Foundation, Huazhong University of Science and Technology, National Institutes of Health, Stand Up To Cancer, Japan Society for the Promotion of Science, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer, Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways, G1327305488, G148836555, Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center, G2214254730, G2350719019, G2453551107, G2657392413, Accelerating Transdisciplinary Epidemiology of Colorectal Cancer, Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center, Dietary and Hormonal Determinants of Cancer in Women, Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer, G4185274752, G46527388, NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care, Mentored Patient-Oriented Research in Digestive Diseases, Prospective Studies of Diet and Cancer in Men and Women, G7355317037, Development of new colorectal cancer treatments through targeting the gut microbiota that influence antitumor immunity and the efficacy of cancer chemotherapies., Cancer Epidemiology Cohort in Male Health Professionals, Lifestyle, genetics and colonoscopy for colorectal cancer prevention, G8225661566, Alliance for Clinical Trials in Oncology Operations Center, G9000005974, G9000025006, G9000030738, G9000031644, G9000043482, G9000099730, G9000184009, G9000206464, Cancer Center Support Grant, Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity, Cancer Epidemiology Cohort in Male Health Professionals, G914912716
OpenAlex ID: W2918209888